R&D

UK Do-I (UDI) is a very market-oriented and R&D-driven company and as one of its significant functions it always serves client companies under global strategic network, especially by delivering well-screened strong points from Japan and China in terms of technology and products.

The relation between UDI and its client companies in the world is very flexible one. All services provided by UDI are very tailor-made and customized to meet exactly with each client’s need in pharmaceutical industry.

With this background, UDI strictly manages its R&D activities to support client companies to enter into market with specialty products as FDF or API. In generic business, UDI understands that the time-to-market is the most important concern to client companies and usually UDI is working with them from early development to market launch and also UDI has enough experiences in long journey of generic product development process for specialty pharmaceuticals.

The number of researchers at R&D is not quite large however every Ph.D. has enough background and experiences in wide range of development status from laboratory to commercial in chemistry or biotechnology. Furthermore, they always appreciate any feed-back given by client companies and reflect this in next segment of R&D activity.